Greening the Firm: The Politics of Corporate Environmentalism

GO Greening the Firm: The Politics of Corporate Environmentalism


Author: Aseem Prakash
Type: eBook
Language: English
Released: 2000
Publisher: No
Page Count: 196
Format: pdf
ISBN-10: 0521662494
ISBN-13: 9780511016875
Tags:Greening the Firm: The Politics of Corporate Environmentalism, tutorials, pdf, djvu, chm, epub, ebook, book, torrent, downloads, rapidshare, filesonic, hotfile, fileserve


Description:
Review Praise for the Series"This classic and essential series presents critical overviews on select aspects of both cancer research and the basic underlying sciences."--AMERICAN SCIENTIST"Excellent, highly informative, in-depth reviews... expertly written, up-to-date, and well-referenced."--JOURNAL OF MEDICINAL CHEMISTRY From the Back Cover This latest volume in Advances in Cancer Research once again proves to be a first-rate source of the best research in the field. Volume 78 contains five comprehensive reviews, beginning with Zwerschke and Jansen-Durr summarizing the available data on the interaction of E7 with cellular regulatory factors and the functional consequences of these interactions. In Chapter 2, Alan Wells focuses on the emerging understanding of the biochemical and biophysical foundations of growth factor-induced cell motility and tumor cell invasiveness and the implications for development of targeted agents, with particular emphasis on signaling from the EGF and HGF receptors, as these have most often been associated with tumor invasion. Chapter 3, by Mignatti and Rifkin, discusses the structure of ECM-degrading proteinases and their interactions with cell membrane and ECM components. Murakami-Mori, Mori, and Bonavida address the issues of and outline recent advances in the molecular pathogenesis of Kaposi's sarcoma. Using cultured KS tumor cells, they have studied intracellular molecular events underlying the growth and apoptosis of these cells. Finally, Kelloff provides an overview of the progress in the field of chemoprevention and concludes with a discussion of the major issues and challenges of chemoprevention drug development and the tremendous opportunity it promises for reduction of cancer in humans.